Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Weight loss drug maker sinks 25% after new safety data spooks investors

EconomyDaily Composite
ShareXFacebook

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement